Related Experiment Video
Updated: Jun 11, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Irritable Bowel Syndrome in the Elderly Population: A Comprehensive Review
Elva R Valtierra Oba1, Ana C Anguiano Morán2, Elizabeth Calderón Cortes3
1Nursing, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, MEX.
Irritable bowel syndrome (IBS) affects adults and older adults, involving gut-brain interactions and microbiota changes. Probiotics and non-pharmacological methods offer safer treatment options for the elderly.
Area of Science:
- Gastroenterology
- Geriatrics
- Microbiology
Background:
- Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder.
- IBS presents with abdominal pain and altered bowel habits, often co-occurring with psychological issues like anxiety and depression.
- Emerging evidence implicates gut-brain axis disorders, gut microbiota dysbiosis, and aging in IBS pathogenesis.
Purpose of the Study:
- To critically review recent literature on Irritable Bowel Syndrome (IBS) in adults and older adults.
- To address the need for consolidated guidelines for IBS management, particularly in the elderly.
- To highlight safe and accessible treatment options for IBS.
Main Methods:
- Literature review of recent scientific findings on IBS.
- Analysis of etiological factors including gut-brain interaction, microbiota, and aging.
- Evaluation of treatment strategies, focusing on pharmacotherapy and non-pharmacological options.
Main Results:
- IBS is prevalent in adults and older adults, with complex etiopathogenesis.
- Psychological factors, gut microbiota alterations, and aging play significant roles.
- Pharmacotherapy requires caution in the elderly due to risk-benefit considerations.
Conclusions:
- Probiotics and non-pharmacological treatments are presented as safe and accessible alternatives for IBS management.
- Clinicians must consider the unique biopsychosocial factors of older adults when treating IBS.
- There is a clear need for updated, consolidated guidelines for IBS treatment.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...